SEC Filing Summary: LeMaitre Vascular, Inc. (LMAT)
Business Context and Reporting Period
This Form 8-K was filed on October 28, 2021, by LeMaitre Vascular, Inc., a Delaware corporation. The filing serves to report the issuance of a press release containing preliminary financial and operational results for the quarter ended September 30, 2021.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references a press release (Exhibit 99.1) as the source for these preliminary results, but the content of that exhibit is not included in the input text.
Material Changes
No material changes versus the prior comparable period are detailed in this document. The filing acts solely as a notification that preliminary results for the quarter ended September 30, 2021, have been issued.
Guidance, Outlook, and Risks
The filing does not provide specific guidance, outlook, management commentary, or risk factors. It explicitly states that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings except as expressly set forth.
Investor Verification Checklist
- Review the full text of the press release (Exhibit 99.1) to obtain actual revenue, earnings, and operational metrics for the quarter ended September 30, 2021.
- Verify the legal status of the preliminary data, noting the disclaimer that it is not "filed" under Section 18 of the Exchange Act.
- Confirm the identity of the signatory, Joseph P. Pellegrino, Jr., Chief Financial Officer, who authorized the report.